TFF Pharmaceuticals Nears Liquidation as Asset Sale Process Continues
The dissolution of TFF Pharmaceuticals is now in its final stages. Following the strategic decision to wind down operations, company leadership is focused on monetizing its core technology platform. For shareholders, the pivotal question remains whether any capital will be available for distribution after all creditor obligations are settled. The company’s financial position is critical.…

